Search Results - "Harada, Sachio"
-
1
Streptococcal preparation OK432 promotes functional maturation of human monocyte-derived dendritic cells
Published in Cancer Immunology, Immunotherapy (01-04-2003)“…Streptococcal preparation OK432 is an immunomodulatory agent extensively used as adjuvant therapy for gastric cancer in Japan. OK432 augments the cytotoxic…”
Get full text
Journal Article -
2
Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy
Published in Cancer Immunology, Immunotherapy (01-03-2007)“…Recent studies have suggested that dendritic cell (DC)-based immunotherapy is one promising approach for the treatment of cancer. We previously studied the…”
Get full text
Journal Article -
3
A case of rectal cancer with bilateral pulmonary metastasis successfully treated with neoadjuvant chemotherapy and SBRT
Published in Annals of oncology (01-11-2015)Get full text
Journal Article -
4
SCID-repopulating cell activity of human cord blood–derived CD34−cells assured by intra–bone marrow injection
Published in Blood (15-04-2003)“…Precise analysis of human CD34-negative (CD34−) hematopoietic stem cells (HSCs) has been hindered by the lack of a simple and reliable assay system of these…”
Get full text
Journal Article -
5
Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: Possible application for cancer immunotherapy
Published in International journal of oncology (01-06-2007)“…Current in vitro culture systems allow the generation of human dendritic progenitor cells (CFU-DCs). The aim of this study was to assess the effect of Flt3…”
Get full text
Journal Article -
6
Role of human interleukin-9 as a megakaryocyte potentiator in culture
Published in Experimental hematology (01-12-2002)“…This study investigated the effect of interleukin-9 (IL-9) on the proliferation and differentiation of human colony-forming unit megakaryocytic progenitor…”
Get full text
Journal Article -
7
Signal through gp130 Activated by Soluble Interleukin (IL)‐6 Receptor (R) and IL‐6 or IL‐6R/IL‐6 Fusion Protein Enhances Ex Vivo Expansion of Human Peripheral Blood‐Derived Hematopoietic Progenitors
Published in Stem cells (Dayton, Ohio) (01-01-2000)“…This study was designed to investigate the effects of a combination of soluble interleukin (sIL)‐6 receptor (R) and IL‐6 on the ex vivo expansion of human…”
Get full text
Journal Article -
8
Mobilization of peripheral blood stem cells (PBSCs) after etoposide, adriamycin and cisplatin therapy, and a multimodal cell therapy approach with PBSCs in advanced gastric cancer
Published in Oncology reports (01-08-2004)“…The EAP combination of etoposide (ETP), doxorubicin (ADM) and cisplatin (CDDP) has been reported to be highly active for advanced gastric cancer. However, it…”
Get more information
Journal Article -
9
Interleukin 6 receptor expression by human cord blood‐ or peripheral blood‐derived primitive haematopoietic progenitors implies acquisition of different functional properties
Published in British journal of haematology (01-08-2000)“…The significance of interleukin 6 receptor (IL‐6R) expression by cord blood (CB)‐ and peripheral blood (PB)‐derived primitive haematopoietic progenitors was…”
Get full text
Journal Article